Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Steinberg

Showing results (841-850 of 1,520) with videos related to

Pageof 152
Sort By:
Tobacco Induced Diseases|July 20, 2022
Association between objective measures and parent-reported measures of child tobacco smoke exposure: A secondary data analysis of four trialsMichal Bitan, David M Steinberg, Sandra R Wilson, et al.
Frontiers in Endocrinology|January 24, 2019
Tetrac Delayed the Onset of Ocular Melanoma in an Orthotopic Mouse ModelOsnat Ashur-Fabian, Ofira Zloto, Ina Fabian, et al.
Drugs Under Experimental and Clinical Research|June 1, 2005
Animal models and analytical approaches for understanding the relationships between wine and cancerS E Ebeler, K H Dingley, E Ubick, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000
Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient miceL K Petiniot, Z Weaver, C Barlow, et al.
The American Journal of Psychiatry|July 1, 1996
Basal cortisol, dexamethasone suppression of cortisol, and MHPG in adolescents after the 1988 earthquake in ArmeniaA K Goenjian, R Yehuda, R S Pynoos, et al.
Statistics in Medicine|April 27, 2010
The statistics of phase 0 trialsLarry V Rubinstein, Seth M Steinberg, Shivaani Kummar, et al.
Leukemia & Lymphoma|January 11, 2019
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomasJoseph Roswarski, Mark Roschewski, Christopher Melani, et al.
BMJ Open|May 21, 2015
Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trialVladimir Neychev, Seth M Steinberg, Candice Cottle-Delisle, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 1, 1994
Photodynamic therapy using m-tetra(hydroxyphenyl) chlorin. An animal modelL A Lofgren, A M Ronn, A L Abramson, et al.
Clinical Chemistry and Laboratory Medicine|December 14, 2011
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancersElad Sharon, Jingli Zhang, Kevin Hollevoet, et al.
Pageof 152

Showing results (841-850 of 1,520) with videos related to

Sort By:
Pageof 152
Tobacco Induced Diseases|July 20, 2022
Association between objective measures and parent-reported measures of child tobacco smoke exposure: A secondary data analysis of four trialsMichal Bitan, David M Steinberg, Sandra R Wilson, et al.
Frontiers in Endocrinology|January 24, 2019
Tetrac Delayed the Onset of Ocular Melanoma in an Orthotopic Mouse ModelOsnat Ashur-Fabian, Ofira Zloto, Ina Fabian, et al.
Drugs Under Experimental and Clinical Research|June 1, 2005
Animal models and analytical approaches for understanding the relationships between wine and cancerS E Ebeler, K H Dingley, E Ubick, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2000
Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient miceL K Petiniot, Z Weaver, C Barlow, et al.
The American Journal of Psychiatry|July 1, 1996
Basal cortisol, dexamethasone suppression of cortisol, and MHPG in adolescents after the 1988 earthquake in ArmeniaA K Goenjian, R Yehuda, R S Pynoos, et al.
Statistics in Medicine|April 27, 2010
The statistics of phase 0 trialsLarry V Rubinstein, Seth M Steinberg, Shivaani Kummar, et al.
Leukemia & Lymphoma|January 11, 2019
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomasJoseph Roswarski, Mark Roschewski, Christopher Melani, et al.
BMJ Open|May 21, 2015
Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trialVladimir Neychev, Seth M Steinberg, Candice Cottle-Delisle, et al.
Archives of Otolaryngology--Head & Neck Surgery|December 1, 1994
Photodynamic therapy using m-tetra(hydroxyphenyl) chlorin. An animal modelL A Lofgren, A M Ronn, A L Abramson, et al.
Clinical Chemistry and Laboratory Medicine|December 14, 2011
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancersElad Sharon, Jingli Zhang, Kevin Hollevoet, et al.
Pageof 152